Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 28, 2003. The report is a notification of changes in directors' interests in the company's Ordinary Shares, specifically regarding the SmithKline Beecham Employee Benefit Trust.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to corporate governance disclosures regarding share ownership and does not contain financial performance data.
Material Changes
On January 24, 2003, the Administrators of the SmithKline Beecham Employee Benefit Trust transferred 5,758 Ordinary shares to participants of the SmithKline Beecham 1991 Share Option Plan. This transaction was notified to the company on January 28, 2003.
Outlook, Risks, and Management Commentary
The filing contains no guidance, outlook, or management commentary regarding future business performance. No risks, contingencies, or unusual items are disclosed in this specific report.
Key Facts for Investor Verification
- 5,758 Ordinary shares were transferred from the Employee Benefit Trust to option plan participants.
- Directors Dr J P Garnier and John Coombe hold interests in the Trust in the same capacity as other employees.
- The filing does not include financial results; investors should refer to the company's Form 20-F for financial data.